GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Farmak PJSC (UKEX:FARM) » Definitions » EPS (Diluted)

Farmak PJSC (UKEX:FARM) EPS (Diluted) : ₴158.10 (TTM As of Dec. 2020)


View and export this data going back to 2010. Start your Free Trial

What is Farmak PJSC EPS (Diluted)?

Farmak PJSC's Earnings per Share (Diluted) for the six months ended in Dec. 2020 was ₴158.10. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was ₴158.10.

Farmak PJSC's EPS (Basic) for the six months ended in Dec. 2020 was ₴158.10. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2020 was ₴158.10.

Farmak PJSC's EPS without NRI for the six months ended in Dec. 2020 was ₴160.24. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2020 was ₴160.24.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Farmak PJSC EPS (Diluted) Historical Data

The historical data trend for Farmak PJSC's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Farmak PJSC EPS (Diluted) Chart

Farmak PJSC Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 94.19 115.30 144.40 145.30 158.10

Farmak PJSC Semi-Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 94.19 115.30 144.40 145.30 158.10

Competitive Comparison of Farmak PJSC's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Farmak PJSC's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Farmak PJSC's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Farmak PJSC's PE Ratio distribution charts can be found below:

* The bar in red indicates where Farmak PJSC's PE Ratio falls into.



Farmak PJSC EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Farmak PJSC's Diluted EPS for the fiscal year that ended in Dec. 2020 is calculated as

Diluted EPS (A: Dec. 2020 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(1149.699-0)/7.273
=158.08

Farmak PJSC's Diluted EPS for the quarter that ended in Dec. 2020 is calculated as

Diluted EPS (Q: Dec. 2020 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(1149.699-0)/7.273
=158.08

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was ₴158.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Farmak PJSC  (UKEX:FARM) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Farmak PJSC EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Farmak PJSC's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Farmak PJSC (UKEX:FARM) Business Description

Traded in Other Exchanges
N/A
Address
63 Kyrylivska Street, Kyiv, UKR, 04080
Farmak PJSC is a Ukraine based company engaged in the production and distribution of generic pharmaceutical drugs. Its products include Endocrinology drugs, Diagnostic drugs, Cardiac drugs, and other medications. The products are mainly sold in Ukraine and exported to many other countries.